Related Experiment Video
Updated: Aug 7, 2026
13:34
Assessing the Development of Murine Plasmacytoid Dendritic Cells in Peyer's Patches Using Adoptive Transfer of Hematopoietic Progenitors
Published on: March 17, 2014
Prostaglandin E2 is a negative regulator on human plasmacytoid dendritic cells
Yonsu Son1, Tomoki Ito, Yoshio Ozaki
1The First Department of Internal Medicine, Kansai Medical University, Osaka, Japan.
Immunology
|June 10, 2006
Summary
Prostaglandin E2 (PGE2) negatively regulates both myeloid dendritic cells (MDCs) and plasmacytoid dendritic cells (PDCs). PGE2 induces PDC death and suppresses immune signaling in both cell types, impacting adaptive immunity.
Area of Science:
- Immunology
- Cell Biology
- Lipid Mediators
Background:
- Prostaglandin E2 (PGE2) is a lipid mediator involved in immune responses, known to inhibit interleukin-12 production by myeloid dendritic cells (MDCs) and promote T helper type 2 (Th2) cell responses.
- The specific role of PGE2 in regulating plasmacytoid dendritic cells (PDCs), crucial for immunity against viruses, allergies, and autoimmune diseases, remains largely uncharacterized.
Purpose of the Study:
- To compare the biological effects of Prostaglandin E2 (PGE2) on human plasmacytoid dendritic cells (PDCs) and myeloid dendritic cells (MDCs).
- To elucidate the regulatory function of PGE2 in the context of innate and adaptive immune responses mediated by these dendritic cell subsets.
Main Methods:
- Comparative analysis of human PDCs and MDCs treated with PGE2.
- Assessment of cell viability, cytokine production (interferon-alpha, interleukin-12), and T helper type 1 (Th1) cell induction capacity following PGE2 pretreatment and stimulation with various agents (virus, cytosine-phosphate-guanosine, lipopolysaccharide, poly(I:C)).
Main Results:
- PGE2 induced cell death in PDCs, whereas MDCs survived the treatment.
- PGE2 inhibited interferon-alpha production by PDCs stimulated with virus or cytosine-phosphate-guanosine.
- PGE2 inhibited interleukin-12 production by MDCs stimulated with lipopolysaccharide (LPS) or poly(I:C).
- PGE2 pretreatment attenuated the Th1-inducing capacity of both virus-stimulated PDCs and LPS-stimulated MDCs.
Conclusions:
- PGE2 acts as a negative regulator for both myeloid dendritic cells (MDCs) and plasmacytoid dendritic cells (PDCs).
- PGE2 influences PDC viability and suppresses key immune signaling pathways in both MDC and PDC subsets, thereby modulating adaptive immune responses.
More Related Videos
Related Concept Videos
01:23Negative Regulator Molecules
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
01:24T Cell Types and Functions
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
02:23Abnormal Proliferation
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
01:22Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.